Madrigal Pharmaceuticals, Inc. (MDGL)
496.97
-7.98
(-1.58%)
USD |
NASDAQ |
Jan 21, 16:00
497.00
+0.03
(+0.01%)
After-Hours: 20:00
Madrigal Pharmaceuticals Free Cash Flow: -164.63M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Eli Lilly & Co. | 6.436B |
| Amgen, Inc. | 11.54B |
| Crinetics Pharmaceuticals, Inc. | -356.03M |
| Amicus Therapeutics, Inc. | 9.691M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 79.85M |
| Cash from Investing (Quarterly) | -207.00M |
| Cash from Financing (Quarterly) | 236.65M |
| Free Cash Flow Per Share (Quarterly) | 3.380 |
| Free Cash Flow to Equity (Quarterly) | -146.46M |
| Free Cash Flow to Firm (Quarterly) | 83.44M |
| Free Cash Flow Yield | -1.49% |